25 May 2013
Keywords: GlaxoSmithKline, Human Genome, M&A
Article | 26 August 2009
Suggestions that UK drug giant GlaxoSmithKline is planning a takeover of development partner Human Genome Sciences for $30/share - or ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
26 August 2009
25 August 2009
24 May 2013
© 2013 thepharmaletter.com